期刊文献+

阿维A治疗寻常型银屑病的疗效及对血清VEGF、IL-6的影响 被引量:7

Efficacy of Acitretin on Patients with Psoriasis Vulgaris and Its Effect on Serum Vascular Endothelial Growth Factor,Interleukin-6
下载PDF
导出
摘要 目的观察阿维A治疗中、重度寻常型银屑病的临床疗效及其对血清血管内皮生长因子(VEGF)、白细胞介素-6(IL-6)水平的影响。方法 32例银屑病患者口服阿维A治疗,疗程8周,治疗前后采用银屑病皮损面积和严重程度指数评分标准(PASI)进行疗效评定;采用酶联免疫吸附试验(ELISA)测定患者治疗前后血清VEGF和IL-6水平并与18例健康对照组比较。结果 32例中、重度寻常型银屑病患者治疗8周后有效率为87.50%;治疗后血清VEGF、IL-6水平明显低于治疗前(P<0.01);银屑病患者血清VEGF、IL-6水平与PASI评分呈正相关(P均<0.01);银屑病患者治疗前、治疗后血清VEGF、IL-6均显著高于健康对照组(P<0.01)。结论阿维A治疗中、重度寻常型银屑病有较好疗效,其作用机制可能与抑制患者血清IL-6、VEGF有关。 Objective To study the therapeutic effect of acitretin on moderate or severe psoriasis vulgaris and effect of acitretin on serum levels of vascular endothelial growth factor ( VEGF ) , interleukin ( IL )-6 .Methods Thirty-two patients with psoriasis vulgaris were treated with oral acitretin ,and the treatment lasted for 8 weeks.The efficacy of treatment was evaluated by Psoriasis Area and Severity Index ( PASI) scores.The levels of VEGF and IL-6 in serum of patients were detected by enzyme-linked immunosorbent assay ( ELISA ) , and were compared with the healthy controls(18 cases).Results The effective rate was up to 87.50%in 32 cases of moderate or severe psoriasis vulgaris after 8-week treatment .The serum levels of VEGF and IL-6 after treatment were significantly lower than those before treatment ( P〈0 .01 ) .The serum levels of VEGF and IL-6 correlated with PASI scores positively in psoriasis patients(P〈0.01).The serum levels of VEGF and IL-6 of psoriasis patients were significantly higher than those of control group before and after treatment ( P 〈0 .01 ) .Conclusion Acitretin has better effect on the treatment of moderate or severe psoriasis vulgaris by inhibiting the serum levels of IL-6 and VEGF.
出处 《广西医学》 CAS 2014年第6期718-721,共4页 Guangxi Medical Journal
基金 湖北省自然科学基金资助项目(2010CDB11001) 广西医药卫生科研课题(Z2013215)
关键词 银屑病 阿维A 血管内皮生长因子 白介素-6 Psoriasis Acitretin Vascular endothelial growth factor Interleukin-6
  • 相关文献

参考文献16

  • 1Rich P, Sigurgeirsson B, Thaci D, et al. Secukinumab in- duction and maintenance therapy in moderate-to-severe plaque psoriasis : a randomized, double-blind, placebo-con- trolled, phase Ⅱ regimen-finding study [ J ]. Br J Dermatol, 2013,168 (2) :402 -411.
  • 2Coimbra S, Oliveira H, Belo L, et al. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy : a follow-up study [ J ]. Am J Clin Dermatol,2013,14 ( 1 ) :49 - 53.
  • 3Gustafson C J, Watkins C, Hix E, et al. Combination therapy in psoriasis : an evidence-based review[ J ]. Am J Clin Der- matol,2013,14( 1 ) :9 - 25.
  • 4van de Kerkhof PC. The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion[ J ]. Br J Dermatol, 1997,137 (4) :661 -662.
  • 5Roberson ED, Boweoek AM. Psoriasis genetics:breaking the barrier[ J]. Trends Genet ,2010,26(9 ) :415 - 423.
  • 6Crawshaw AA, Griffiths CE, Young HS. Investigational VEGF antagonists for psoriasis [ J ]. Expert Opin Investig Drugs, 2012,21 ( 1 ) :33 -43.
  • 7Heidenreich R, Rficken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis [ J ]. Int J Exp Patho1,2009,90 (3) : 232 - 248.
  • 8Mccall CO. Psoriasis: Clinical Features and Pathology [ J ]. Pathology Case Reviews, 2011,16 ( 1 ) : 2 - 9.
  • 9Schonthaler HB, Huggenberger R,Wculek SK,et al. Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis [ J ]. Proc Nat Acad Sci USA, 2009,106(50) :21 264 -21 269.
  • 10Gaengel K, Betsholtz C. Endocytosis regulates VEGF signal- ling during angiogenesis [ J]. Nat Cell Biol, 2013,15 ( 3 ) : 233 - 235.

同被引文献101

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部